Stockreport

Skye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights

Skye Bioscience, Inc.  (SKYE) 
PDF SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ: SKYE) (“Skye” or the “Company”), a clinical-stage biopharmaceutical company focused on unlo [Read more]